According to a new report by Polaris Market Research, the global addiction treatment market was valued at USD 6.41 billion in 2025 and is projected to reach USD 10.42 billion by 2034, expanding at a CAGR of 5.54% over the forecast period. Growth is underpinned by the rising prevalence of addiction disorders, growing awareness and acceptance of treatment options, and accelerating adoption of digital and AI-enabled therapeutic tools.

What Is Driving Addiction Treatment Market Growth?

Demand is climbing as rising global alcohol and drug consumption converges with expanding government support for rehabilitation programs. Providers are prioritizing telehealth and digital monitoring tools, pushing addiction treatment adoption across hospital pharmacies, rehabilitation centers, and residential facilities. Polaris analysts note that 44.6 million individuals aged 12 and above — 15.3% of the U.S. population — had a substance use disorder in 2025 according to SAMHSA, positioning the market for sustained growth through 2034, with North America emerging as the largest revenue contributor and Asia Pacific posting the fastest incremental gains.

Key Trends Shaping the Addiction Treatment Industry

Rising Consumption of Alcohol and Drugs

UK data shows 329,646 adults received drug and alcohol treatment services between April 2024 and March 2025, a 6% annual increase, reflecting the sustained demand for detoxification, inpatient rehabilitation, and outpatient counseling driving industry trends.

Adoption of AI, Telehealth, and Digital Monitoring

Digital therapeutics, wearable biosensors, and AI-driven relapse prediction are expanding treatment access outside traditional clinical settings, with CHESS Health's September 2025 statewide Arkansas rollout illustrating the sector's growing market outlook.

Expansion Into Personalized and At-Home Care

Providers are increasingly integrating electronic health records with addiction-treatment elements and offering at-home care pathways, supporting a more efficient, outcome-focused competitive landscape that draws sustained investment.

Browse In-depth Market Research Report:

https://www.polarismarketresearch.com/industry-analysis/global-addiction-treatment-market 

Market Segmentation: Breaking Down the Addiction Treatment Market

Polaris segments the addiction treatment market by treatment type, treatment centers, distribution channel, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Treatment Type

The tobacco/nicotine addiction segment is anticipated to grow at a considerable 5.20% CAGR through 2034, driven by expanded cigarette smoking prevalence among the younger, Gen-Z population and their growing preference for smoking-cessation medication.

By Treatment Centers

Rehabilitation centers accounted for a 39.0% market share in 2025, reflecting their extensive service offerings, while residential and inpatient centers continue to serve patients requiring more intensive, round-the-clock supervision.

By Distribution Channel

Hospital pharmacies accounted for the largest revenue share of 45.0% in 2025, supported by easy availability of varied medicine dosages and growing drug-awareness campaigns, signaling where near-term demand for addiction treatment is concentrated.

Regional Outlook: Where Is Addiction Treatment Growing Fastest?

North America dominated the global market with a 38.0% revenue share in 2025, driven by high rates of opioid, stimulant, and alcohol use disorder along with a well-established reimbursement system, while Asia Pacific is expected to post a 6.80% CAGR through 2034, driven by a large younger population consuming tobacco and alcohol at a rapid pace. Within North America, the U.S. remains the largest single market; within Asia Pacific, India is a primary growth engine. Europe rounds out the top three, supported by established treatment infrastructure across the UK, Germany, and France.

Competitive Landscape: Leading Addiction Treatment Companies

Key players profiled in the report include Indivior plc, Alkermes plc, Hikma Pharmaceuticals plc, and Teva Pharmaceutical Industries Ltd., who are focusing on telemedicine integration, mental-healthcare partnerships, and clinically proven treatment approaches to strengthen market position across the rehabilitation centers and hospital pharmacies segments outlined above. Recent moves include DemeRx's April 2026 FDA IND acceptance for its noribogaine therapeutic DMX-1001 and NIDA's March 2026 clinical trial results supporting extended-release buprenorphine for opioid use disorder during pregnancy, both aimed at expanding the pharmacotherapy pipeline.

Why It Matters for Buyers Evaluating Addiction Treatment Market Entry

For stakeholders researching the addiction treatment market forecast, this report benchmarks market share, segment-level pricing, and forecast data — by treatment type, treatment centers, distribution channel, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking tobacco/nicotine addiction treatment as a growth adjacency.

More Trending Latest Reports By Polaris Market Research:

Outdoor Air Quality Monitoring System Market

Digital Identity Solutions Market

Secure Access Service Edge Market

Speech-to-text API Market

Data Center Infrastructure Management Market

Convergent billing Market

Project Portfolio Management (PPM) Market

Subscriber Data Management Market

5G in Defense Market